Structure Database (LMSD)

LM_ID Common Name Systematic Name Main class Sub class Mass Formula
LMSP0506BB08 Fucalpha1-2Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1673 C82H148N2O32
LMSP0506AN08 Galalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1526.94 C76H138N2O28
LMSP0506AU08 Galbeta1-4GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1526.94 C76H138N2O28
LMSP0506BI02 Fucalpha1-3GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1603.92 C76H137N3O32
LMSP0506AA05 Fucalpha1-2Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1281.85 C66H123NO22
LMSP0506AZ05 Galalpha1-3(Fucalpha1-2)Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1281.85 C66H123NO22
LMSP0506AZ08 Galalpha1-3(Fucalpha1-2)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1307.87 C68H125NO22
LMSP0506BD02 Galalpha1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1213.75 C60H111NO23
LMSP0506AP08 Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1364.89 C70H128N2O23
LMSP0506AZ02 Galalpha1-3(Fucalpha1-2)Galbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1197.76 C60H111NO22
LMSP0506AU04 Galbeta1-4GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1472.9 C72H132N2O28
LMSP0506AU03 Galbeta1-4GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1444.87 C70H128N2O28
LMSP0506AO02 GalNAcbeta1-3Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1457.86 C70H127N3O28
LMSP0506BJ01 Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1737.94 C80H143N3O37
LMSP0506BH08 Galbeta1-4GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1730.02 C84H151N3O33
LMSP0506BH03 Galbeta1-4GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1647.94 C78H141N3O33
LMSP0506BH02 Galbeta1-4GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1619.91 C76H137N3O33
LMSP0506BA07 Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1660.97 C80H144N2O33
LMSP0506AV03 Fucalpha1-3GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1428.87 C70H128N2O27
LMSP0506BA05 Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1662.98 C80H146N2O33
LMSP0506BF04 Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1310.84 C66H122N2O23
LMSP0506AJ05 GalNAcbeta1-3Galalpha1-3(GalNAcbeta1-4Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1907.09 C90H162N4O38
LMSP0506AT06 GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1366.91 C70H130N2O23
LMSP0506AL01 GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1632.91 C76H136N4O33
LMSP0506AW08 Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1673 C82H148N2O32
LMSP0506AW06 Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1675.02 C82H150N2O32
LMSP0506AM05 Galalpha1-3(GalNAcbeta1-4Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1704.01 C82H149N3O33
LMSP0506AW02 Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1562.89 C74H134N2O32
LMSP0507AA07 Manalpha1-3Manbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] Manalpha1-3Manbeta1-4Glc- (Mollu series) [SP0507] 1133.78 C60H111NO18
LMSP0507AA04 Manalpha1-3Manbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] Manalpha1-3Manbeta1-4Glc- (Mollu series) [SP0507] 1107.76 C58H109NO18
LMSP0507AA01 Manalpha1-3Manbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Manalpha1-3Manbeta1-4Glc- (Mollu series) [SP0507] 1023.67 C52H97NO18
LMSP0507AA03 Manalpha1-3Manbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] Manalpha1-3Manbeta1-4Glc- (Mollu series) [SP0507] 1079.73 C56H105NO18
LMSP0507AA02 Manalpha1-3Manbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] Manalpha1-3Manbeta1-4Glc- (Mollu series) [SP0507] 1051.7 C54H101NO18
LMSP0507AA08 Manalpha1-3Manbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Manalpha1-3Manbeta1-4Glc- (Mollu series) [SP0507] 1161.81 C62H115NO18
LMSP0507AA06 Manalpha1-3Manbeta1-4Glcbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] Manalpha1-3Manbeta1-4Glc- (Mollu series) [SP0507] 1163.83 C62H117NO18
LMSP0507AA05 Manalpha1-3Manbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] Manalpha1-3Manbeta1-4Glc- (Mollu series) [SP0507] 1135.8 C60H113NO18
LMSP0508AA07 GlcNAcbeta1-4Manbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] GlcNAcbeta1-4Manbeta1-4Glc- (Arthro series) [SP0508] 1174.81 C62H114N2O18
LMSP0508AA08 GlcNAcbeta1-4Manbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] GlcNAcbeta1-4Manbeta1-4Glc- (Arthro series) [SP0508] 1202.84 C64H118N2O18
LMSP0508AA02 GlcNAcbeta1-4Manbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] GlcNAcbeta1-4Manbeta1-4Glc- (Arthro series) [SP0508] 1092.73 C56H104N2O18
LMSP0508AA03 GlcNAcbeta1-4Manbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] GlcNAcbeta1-4Manbeta1-4Glc- (Arthro series) [SP0508] 1120.76 C58H108N2O18
LMSP0508AA04 GlcNAcbeta1-4Manbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] GlcNAcbeta1-4Manbeta1-4Glc- (Arthro series) [SP0508] 1148.79 C60H112N2O18
LMSP0508AA06 GlcNAcbeta1-4Manbeta1-4Glcbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] GlcNAcbeta1-4Manbeta1-4Glc- (Arthro series) [SP0508] 1204.85 C64H120N2O18
LMSP0508AA01 GlcNAcbeta1-4Manbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] GlcNAcbeta1-4Manbeta1-4Glc- (Arthro series) [SP0508] 1064.7 C54H100N2O18
LMSP0508AA05 GlcNAcbeta1-4Manbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] GlcNAcbeta1-4Manbeta1-4Glc- (Arthro series) [SP0508] 1176.82 C62H116N2O18
LMSP0509AA04 Galalpha1-4Galbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] Gal- (Gala series) [SP0509] 945.71 C52H99NO13
LMSP0509AA02 Galalpha1-4Galbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] Gal- (Gala series) [SP0509] 889.65 C48H91NO13
LMSP0509AA03 Galalpha1-4Galbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] Gal- (Gala series) [SP0509] 917.68 C50H95NO13
LMSP0509AA06 Galalpha1-4Galbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] Gal- (Gala series) [SP0509] 1001.77 C56H107NO13
LMSP0509AA01 Galalpha1-4Galbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Gal- (Gala series) [SP0509] 861.62 C46H87NO13
LMSP0509AA07 Galalpha1-4Galbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] Gal- (Gala series) [SP0509] 971.73 C54H101NO13